Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study
154 - BioM - Die Biotech Cluster Development GmbH
Long‐term outcome after COVID‐19 infection in multiple sclerosis: A nation‐wide multicenter matched‐control study - Bsteh - 2022 - European Journal of Neurology - Wiley Online Library
DB-Web-App/ums_brand_words.txt at master · amadorschulze92/DB-Web-App · GitHub